Resilio Therapeutics LLC

Biotechnology company · Durham, North Carolina, United States

Resilio Therapeutics LLC is a biotechnology company headquartered in Durham, North Carolina, United States. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $2.4 million in total, most recently in 2020.

www.resiliotherapeutics.comProfile compiled from public records. Is this your company? Request a correction or update

Resilio Therapeutics at a glance

Typebiotechnology company
HeadquartersDurham, North Carolina, United States
Employees (self-reported, 2020)4

What does Resilio Therapeutics do?

US government research funding

3 SBIR/STTR small-business research awards from US health agencies, $2.4 million in total (2017 to 2020). NIH funding came from the National Institute on Aging, National Institute of Neurological Disorders and Stroke, National Institute of Diabetes and Digestive and Kidney Diseases.

Frequently asked questions about Resilio Therapeutics

Where is Resilio Therapeutics headquartered?

Resilio Therapeutics LLC is headquartered in Durham, North Carolina, United States.

What does Resilio Therapeutics do?

Resilio Therapeutics LLC is a biotechnology company.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences